tetradecanoylphorbol acetate has been researched along with Uveal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cucinotta, M; Oteri, R; Teti, D; Venza, I; Venza, M; Visalli, M | 1 |
| Alizadeh, H; Niederkorn, JY; Pidherney, MS; Taylor, WM | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Uveal Neoplasms
| Article | Year |
|---|---|
Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells.
Topics: Acetylation; Cell Line, Tumor; Cell Proliferation; DNA-Directed RNA Polymerases; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Interleukin-8; Melanoma; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-jun; Pyrroles; RNA, Messenger; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription Factor TFIIB; Transcription, Genetic; Uveal Neoplasms | 2013 |
In vitro characterization of Acanthamoeba castellanii cytopathic effect.
Topics: Acanthamoeba; Animals; Bepridil; Calcimycin; Calcium Channels; Cathepsin C; Cell Survival; Cytochalasin D; Cytoskeleton; Cytotoxicity, Immunologic; Dipeptides; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Immunosuppressive Agents; Killer Cells, Lymphokine-Activated; Melanoma; Microscopy, Electron; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Uveal Neoplasms | 1995 |